Operose Advisors LLC

Position in QNCX — Quince Therapeutics, Inc.

CIK 1909750 MILWAUKEE, WI

Position in QNCX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,892

-$102,860 QoQ

Shares Held

159

+0.6% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#16

of 25 holders

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Operose Advisors LLC holds $754,851 across 5 Biotechnology names. QNCX ranks #5 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IBRX	ImmunityBio, Inc.	62,057	$543,309
2	VKTX	Viking Therapeutics, Inc.	4,714	$183,893
3	CMPX	Compass Therapeutics, Inc.	6,274	$13,740
4	CRSP	CRISPR Therapeutics AG	202	$11,017
5	QNCX	Quince Therapeutics, Inc. This page	159	$2,892

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,892	159	-99.5%	Shares	Sole	2026-08-13
2025-12-31	$105,752	31,568	0.0%	Shares	Sole	2026-02-10
2025-09-30	$51,455	31,568	—	Shares	Sole	2025-11-12
No filing history on record for this holder in this stock.